S&P 500
(-0.15%) 5 464.70 points
Dow Jones
(0.04%) 39 150 points
Nasdaq
(-0.18%) 17 689 points
Oil
(-0.80%) $80.64
Gas
(-1.02%) $2.71
Gold
(-1.44%) $2 335.00
Silver
(-4.01%) $29.59
Platinum
(1.25%) $996.60
USD/EUR
(0.14%) $0.935
USD/NOK
(0.29%) $10.57
USD/GBP
(0.09%) $0.791
USD/RUB
(2.12%) $89.12

Realtime updates for Ind-Swift Laboratories [INDSWFTLAB.NS]

Exchange: NSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated21 Jun 2024 @ 05:59

-0.66% INR 116.49

Live Chart Being Loaded With Signals

Commentary (21 Jun 2024 @ 05:59):
Our systems believe the stock currently is undervalued by -0.18% compare to its pairs and should correct upwards.

Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms...

Stats
Today's Volume 183 331
Average Volume 1.11M
Market Cap 6.88B
EPS INR40.42 ( Q4 | 2024-03-31 )
Next earnings date ( INR0 ) 2024-08-06
Last Dividend INR1.000 ( 2011-09-20 )
Next Dividend INR0 ( N/A )
P/E 1.640
(Sector) 0
(Industry) 0
ATR14 INR0.252 (0.22%)
AARTIDRUGS.NS -2.26%
ALKEM.NS -0.56%
ALPA.NS 3.97%
AMRUTANJAN.NS -1.03%
APLLTD.NS 2.82%
ASTRAZEN.NS -0.40%
AUROPHARMA.NS -0.17%
BAFNAPH.NS 0.00%
BALPHARMA.NS 2.02%
BIOFILCHEM.NS -0.81%
BLISSGVS.NS 0.82%
BROOKS.NS 0.69%
CADILAHC.NS 0.03%
DIVISLAB.NS 0.40%
DRREDDY.NS 0.68%
ERIS.NS 1.08%
FDC.NS 0.49%
GLENMARK.NS -0.86%
GLS.NS -1.18%
GRANULES.NS 3.89%
GUFICBIO.NS -1.02%
HESTERBIO.NS 20.00%
HIKAL.NS -0.11%
INDOCO.NS 0.57%
INDSWFTLAB.NS -0.66%
IOLCP.NS -1.16%
IPCALAB.NS 0.97%
JBCHEPHARM.NS -2.87%
JUBLPHARMA.NS -1.85%
KILITCH.NS -1.11%
KREBSBIO.NS -2.27%
LASA.NS 0.35%
LAURUSLABS.NS -0.66%
LINCOLN.NS 2.27%
LUPIN.NS 0.34%
MANGALAM.NS -1.36%
MEDICAMEQ.NS -1.24%
MEDICO.NS -1.19%
MOREPENLAB.NS -0.65%
NECLIFE.NS -0.60%
NOVARTIND.NS 0.26%
ORCHPHARMA.NS -1.71%
ORTINLAB.NS 1.28%
PAR.NS -0.94%
PDPL.NS 0.00%
PEL.NS -2.31%
PGHL.NS 0.91%
RPGLIFE.NS 0.72%
SAKAR.NS -0.78%
SEQUENT.NS -1.49%
SHILPAMED.NS 1.35%
SIGACHI.NS -0.30%
SOLARA.NS 0.97%
SPARC.NS -0.15%
STAR.NS -0.31%
SUNPHARMA.NS -0.25%
SUVEN.NS 0.10%
SUVENPHAR.NS -1.41%
SYNCOM.NS 1.19%
SYNCOMF.NS 1.52%
THEMISMED.NS -0.82%
TORNTPHARM.NS -0.94%
Correlation (AI algo v.1.1b): Undervalued: -0.18% INR116.04 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.05 (neutral)
Short: -0.23 (neutral)
Signal:(43.445) Neutral

Ind-Swift Laboratories Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ind-Swift Laboratories Correlation - Currency/Commodity

The country flag -0.36
( neutral )
The country flag -0.23
( neutral )
The country flag 0.00
( neutral )
The country flag -0.06
( neutral )
The country flag 0.00
( neutral )
The country flag 0.20
( neutral )

Ind-Swift Laboratories Financials

Annual 2023
Revenue: INR12.81B
Gross Profit: INR4.13B (32.27 %)
EPS: INR71.24
FY 2023
Revenue: INR12.81B
Gross Profit: INR4.13B (32.27 %)
EPS: INR71.24
FY 2022
Revenue: INR12.07B
Gross Profit: INR5.52B (45.70 %)
EPS: INR8.06
FY 2022
Revenue: INR10.39B
Gross Profit: INR4.28B (41.20 %)
EPS: INR-0.360

Financial Reports:

No articles found.

Ind-Swift Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)
INR0
(N/A)

Ind-Swift Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.20 - good (92.00%) | Divividend Growth Potential Score: 3.47 - No dividend growth expected in the near future
Information
First Dividend INR1.000 2004-09-23
Last Dividend INR1.000 2011-09-20
Next Dividend INR0 N/A
Payout Date 2011-10-26
Next Payout Date N/A
# dividends 8 --
Total Paid Out INR9.00 --
Avg. Dividend % Per Year 0.00% --
Score 2.48 --
Div. Sustainability Score 9.20
Div.Growth Potential Score 3.47
Div. Directional Score 6.33 --
Next Divdend (Est)
(2024-06-27)
INR0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
2.48
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2004 INR1.000 2.11%
2005 INR1.500 0.58%
2006 INR1.500 0.98%
2007 INR1.000 1.85%
2008 INR1.000 1.09%
2009 INR1.000 3.34%
2010 INR1.000 1.31%
2011 INR1.000 0.85%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
20 Sep 2011 INR1.000 25 May 2011 21 Sep 2011 26 Oct 2011
16 Sep 2010 INR1.000 29 May 2010 18 Sep 2010 22 Oct 2010
17 Sep 2009 INR1.000 29 Jun 2009 19 Sep 2009 24 Oct 2009
18 Sep 2008 INR1.000 19 Jun 2008 22 Sep 2008 01 Nov 2008
21 Sep 2007 INR1.000 30 Jul 2007 25 Sep 2007 01 Nov 2007
22 Sep 2006 INR1.500 17 Jun 2006 26 Sep 2006 01 Nov 2006
22 Sep 2005 INR1.500 13 Jun 2005 26 Sep 2005 11 Oct 2005
23 Sep 2004 INR1.000 30 Jun 2004 25 Sep 2004 10 Oct 2004

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
HINDZINC.NS Dividend Royal 2024-05-15 Semi-Annually 18 10.86% 7.69
CUPID.NS Dividend Royal 2023-09-18 Semi-Annually 9 23.43% 7.67
COALINDIA.NS Dividend Royal 2024-02-20 Semi-Annually 14 8.66% 7.17
ASTERDM.NS Ex Dividend King 2024-08-22 Semi-Annually 1 29.70% 6.69
HCLTECH.NS Dividend King 2024-05-07 Quarterly 23 3.22% 6.59
ONGC.NS Dividend King 2024-02-16 Semi-Annually 28 5.67% 6.48
IOC.NS Dividend King 2024-07-12 Semi-Annually 28 8.59% 6.40
NATIONALUM.NS Dividend King 2024-02-23 Semi-Annually 26 4.93% 6.39
FIEMIND.NS Dividend King 2024-07-24 Semi-Annually 18 5.81% 6.26
RITES.NS Dividend King 2024-02-09 Quarterly 7 4.62% 6.21

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2401.5005.207.81[0 - 0.5]
returnOnAssetsTTM0.2641.2001.2131.455[0 - 0.3]
returnOnEquityTTM0.3991.5006.6810.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.050.80010.008.00[1 - 3]
quickRatioTTM2.780.80010.008.00[0.8 - 2.5]
cashRatioTTM1.9951.5000.03040.0457[0.2 - 2]
debtRatioTTM0.0143-1.5009.76-10.00[0 - 0.6]
interestCoverageTTM1.9881.000-0.375-0.375[3 - 30]
operatingCashFlowPerShareTTM13.752.005.4210.00[0 - 30]
freeCashFlowPerShareTTM13.752.003.126.25[0 - 20]
debtEquityRatioTTM0.0178-1.5009.93-10.00[0 - 2.5]
grossProfitMarginTTM0.3541.0007.437.43[0.2 - 0.8]
operatingProfitMarginTTM0.07931.000-0.414-0.414[0.1 - 0.6]
cashFlowToDebtRatioTTM4.891.00010.0010.00[0.2 - 2]
assetTurnoverTTM1.0990.8006.004.80[0.5 - 2]
Total Score9.20

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM2.291.0009.870[1 - 100]
returnOnEquityTTM0.3992.507.8610.00[0.1 - 1.5]
freeCashFlowPerShareTTM13.752.005.426.25[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM13.752.005.4210.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.07141.500-2.860[0.5 - 2]
operatingCashFlowSalesRatioTTM0.06341.000-0.9140[0.1 - 0.5]
Total Score3.47

Ind-Swift Laboratories Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ind-Swift Laboratories

Ind-Swift Laboratories Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, anticholinergic, sedative, hypnotic, alcohol abstinence, and antineoplastic, as well as various products for ADHD symptoms. It provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, aripiprazole, atorvastatin calcium, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, Clarithromycin, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nitazoxanide, quetiapine, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide. The company also offers early and late phase drug development, process research and development, contract and API manufacturing, and custom chemicals and synthesis; and analytical development, regulatory support, chemistry, impurity profiling, isolation, discovery, identification and characterization, and project management services. It also exports its products. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.8420219421387 seconds
Number of API calls: 3
Number of DB calls: 9